Clinical Trial Update: REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects [NA]

View source ↗

Summary

Clinical trial update for REPRISE IV evaluating the LOTUS Edge Valve System in intermediate surgical risk patients with aortic valve stenosis; study terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• LOTUS EDGE Valve System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Aortic Valve Stenosis | NA | Status: TERMINATED | Results posted: 2022-12-27